ECO 2026: gut hormone signals differ in T1D with obesity

Pharmaceutical Technology

At ECO 2026, researchers presented a study assessing fasting PYY, ghrelin and GIP levels in T1D patients, with or without obesity.

pharminent May 14, 2026 (Last updated: May 21, 2026)

Pharmaceutical Technology

At ECO 2026, researchers presented a study assessing fasting PYY, ghrelin and GIP levels in T1D patients, with or without obesity.

Related Stories